Article

Sens. to Sebelius: Support the NIH

Today on Capitol Hill, Department of Health and Human Services Secretary Kathleen Sebelius caught a little guff from Senators Tom Harkin (D-IA) and Arlen Specter (D-PA) about the paltry increase -- just about $442 million -- that HHS is proposing for the National Institutes of Health's 2010 budget. "I would urge you to take another look at that figure," Specter said to Sebelius at a Senate subcommittee linkurl:hearing.;http://www.senate.gov/fplayers/CommPlayer/commFlashPlayer.cfm?fn=appropsA060

Written byBob Grant
| 2 min read
Save for Later
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Today on Capitol Hill, Department of Health and Human Services Secretary Kathleen Sebelius caught a little guff from Senators Tom Harkin (D-IA) and Arlen Specter (D-PA) about the paltry increase -- just about $442 million -- that HHS is proposing for the National Institutes of Health's 2010 budget. "I would urge you to take another look at that figure," Specter said to Sebelius at a Senate subcommittee linkurl:hearing.;http://www.senate.gov/fplayers/CommPlayer/commFlashPlayer.cfm?fn=appropsA060909p&st=35 "We are in jeopardy of losing a generation of young research scientists. And I think we have to maintain the growth rate." Sebelius responded that, in terms of keeping the NIH's funding healthy, she too wants to "make sure we don't reach a cliff and fall off the edge of the cliff." "I share the concern that we continue to invest in science and research," Sebelius said. But she maintained that the $10 billion that NIH scored in the stimulus bill would be enough to carry the agency through some lean budget years. "In putting together the 2010 budget there was a recognition that the Recovery Act funds will fund 2010 and some of the 2011 strategies" for sustaining this overall investment, she said. To this Specter replied that "the stimulus package and that $10 billion," which he had a big hand in securing for the agency, "ought not to be looked at for the regular funding." "We were looking for that to stimulate the economy and for jobs," Specter continued. "It was not the generalization that the stimulus would be used in place of future years' funding. We'd like to maintain NIH funding on its own." Then Harking, the subcommittee chairman, joined in. "I am concerned about the 'cliff,' and the baseline, and what happens to that baseline funding," he said. "To only put in $442 million doesn't do much for getting our baseline up." With Specter and Harkin sitting on the Senate subcommittee responsible for negotiating HHS's federal funding, the NIH may see more money in 2010 than HHS has asked for at first blush. And with record numbers of researchers applying for the NIH's stimulus-cash-fueled Challenge Grants and more likely to belly up to the trough, the agency will likely need it. "[Specter's] going to be dogged on this," said Harkin before adjourning the meeting, "and I am going to be joining with him on it."
**__Related stories:__***linkurl:Science scores in 2010 US budget;http://www.the-scientist.com/blog/display/55681/
[7th May 2009]*linkurl:Life science scores in 2010 budget;http://www.the-scientist.com/blog/display/55483/
[26th February 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Join for free today
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share

Related Research Resources

The Scientist Placeholder Image

From Data to Discovery: Omics in Therapeutic Innovation

Webinar

The Scientist Placeholder Image

Exploring Organoids for Disease Modeling Research

Webinar

The Scientist Placeholder Image

The Translational Potential of Cell and Gene Therapies

Webinar

The Scientist Placeholder Image

Tackling Translational Needs in Gene Editing

Webinar

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Product News

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies